https://www.selleckchem.com/pr....oducts/c-176-sting-i
To document clinical, radiologic, and cellular data of a prospective patient series treated by a tri-layer collagen-hydroxyapatite biomimetic osteochondral scaffold (CHAS) intra-operatively seeded with cultivated autologous chondrocytes (AC) or with filtered bone marrow stem/stromal cells (fBMSC) to address chronic osteochondral knee lesions. Thirty-six consecutive patients (15 to 59years) with chronic osteochondral lesions (1.8-10cm ) in the condylar or patellofemoral knee surfaces were enrolled. Lesions were covered with
Like
Comment
Share
